Our group was recently funded by Portugal2020 to develop new therapies for stroke. The project has the contribution of two Hospitals in the Center Region of Portugal (Hospital Rovisco Pais and Hospital da Universidade de Coimbra) and a company (Crioestaminal). Stroke is the second cause of mortality in the world, and patients that survive to the accident present a high probability of morbidity, i.e., neurologic deficit (motor or cognitive). So far, there is only a therapy approved by FDA for the treatment of ischemic stroke, the tissue plasminogen activator (which should be administered until 3 h after stroke), which has several limitations. The present project aims to create an innovative therapeutic platform to treat stroke patients based in stem cells and their products.
The best poster prize (for biocompatible antimicrobial peptide conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model) in “III Simpósio de Nanociência e Nanotecnologia Biomédica-Nano2016.pt”, held on April 15th, 2016 at Lisbon, has been awarded to our group member Dr. Akhilesh Rai.
Nano2016.pt gathered scientists, which are interested in nanotechnology and nanoscience fields, from all over the world, with the chance of an overlook of contemporary sciences, beyond their own field of research. Together with Dr. Lino Ferreira and Dr. Akhilesh Rai, other members of the group as Dr. Adrián Jiménez and Miguel Lino participated in the Symposium.